BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10944783)

  • 1. The structure of the ring-opened N beta-propyl-ajmaline (Neo-Gilurytmal) at physiological pH is obviously responsible for its better absorption and bioavailability when compared with ajmaline (Gilurytmal).
    Hinse C; Stöckigt J
    Pharmazie; 2000 Jul; 55(7):531-2. PubMed ID: 10944783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence data and studies on the lipid solubility and chemical structure of N-propyl-ajmaline as compared to ajmaline.
    Iven H
    Arzneimittelforschung; 1977; 27(10):1875-9. PubMed ID: 579095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly-detected reductase from Rauvolfia closes a gap in the biosynthesis of the antiarrhythmic alkaloid ajmaline.
    Gao S; von Schumann G; Stöckigt J
    Planta Med; 2002 Oct; 68(10):906-11. PubMed ID: 12391554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of fatal poisoning with the anti-arrhythmia agents Katen and Neo-Gilurytmal].
    Petovský P; Malý J
    Soud Lek; 1997 May; 42(2):18-20. PubMed ID: 9340789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of experimental renal dysfunction on bioavailability of ajmaline in rats.
    Hashimoto Y; Aiba T; Yasuhara M; Hori R
    J Pharm Pharmacol; 2001 Jun; 53(6):805-13. PubMed ID: 11428656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of prajmalium bitartrate (Neo-Gilurytmal) in urine with thin layer chromatography].
    Nováková E
    Pharmazie; 1987 Aug; 42(8):550-1. PubMed ID: 3432338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of prajmaline (Neo-Gilurytmal) objectifiable by means of a test].
    Fortschr Med; 1983 May; 101(17):809-10. PubMed ID: 6190722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics and biotransformation of N-propylajmaline hydrogen tartrate in man].
    Hausleiter HJ; Achtert G; Khan MA; Kukovetz WR; Beubler E
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):329-39. PubMed ID: 7166185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of Neo-Gilurytmal in the treatment of arrhythmias].
    Kedrowa S; Kutarski A
    Pol Tyg Lek; 1976 Feb; 31(6):241-3. PubMed ID: 1257134
    [No Abstract]   [Full Text] [Related]  

  • 10. Vomilenine reductase--a novel enzyme catalyzing a crucial step in the biosynthesis of the therapeutically applied antiarrhythmic alkaloid ajmaline.
    von Schumann G; Gao S; Stöckigt J
    Bioorg Med Chem; 2002 Jun; 10(6):1913-8. PubMed ID: 11937349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and Antiarrhythmic effects of Prajmalium Bitartrate].
    Trompler AT; Woodcock BG; Bussmann WD
    Arzneimittelforschung; 1983; 33(3):436-9. PubMed ID: 6683519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of Neo-Gilurytmal on heart lesions induced with isoprenaline].
    Mitova M; Bednarík B; Foukal T; Papousek F; Cerný E
    Cesk Patol; 1986 May; 22(2):116-20. PubMed ID: 3731295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ajmaline group of indole alkaloids.
    Lounasmaa M; Hanhinen P
    Alkaloids Chem Biol; 2001; 55():1-87. PubMed ID: 11704984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of Neo-Gilurytmal on the excitation-conduction system of the human heart].
    Trusz-Gluza M; Giec L; Zajac T; Kocot A; Hübner D; Kośmider J
    Kardiol Pol; 1982; 25(9):703-8. PubMed ID: 7169756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute anicteric hepatitis and intrahepatic cholestasis caused by administration of prajmalium bitartrate (Neo-Gilurytmal)].
    Trefanec J; Langmeierová M; Zelezná J
    Cas Lek Cesk; 1994 Jan; 133(3):83-5. PubMed ID: 8137378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal pyrazinones: a new class of peptide-bound advanced glycation end-products.
    Krause R; Kühn J; Penndorf I; Knoll K; Henle T
    Amino Acids; 2004 Aug; 27(1):9-18. PubMed ID: 15309567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarpagan-Ajmalan-Type Indoles: Biosynthesis, Structural Biology, and Chemo-Enzymatic Significance.
    Wu F; Kerčmar P; Zhang C; Stöckigt J
    Alkaloids Chem Biol; 2016; 76():1-61. PubMed ID: 26827882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivatization reaction of the mycotoxin moniliformin with 1,2-diamino-4,5-dichlorobenzene: structure elucidation of an unexpected reaction product by liquid chromatography/tandem mass spectrometry and liquid chromatography/nuclear magnetic resonance spectroscopy.
    Zöllner P; Lienau A; Albert K; Lindner W
    J Mass Spectrom; 2003 Jul; 38(7):709-14. PubMed ID: 12898650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of lorajmine and its metabolite ajmaline in plasma and urine by a new high-performance liquid chromatographic method.
    Padrini R; Piovan D; Gaglione E; Zordan R; Ferrari M
    Ther Drug Monit; 1992 Oct; 14(5):391-6. PubMed ID: 1448847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Ajmaline-type Alkaloid from the Roots of Rauvolfia serpentina.
    Rukachaisirikul T; Chokchaisiri S; Suebsakwong P; Suksamrarn A; Tocharus C
    Nat Prod Commun; 2017 Apr; 12(4):495-498. PubMed ID: 30520580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.